Mayo Clinic opens Riyadh office: 5 checks for UAE medical travel teams

Mayo Clinic has opened a patient information office in Riyadh to help Saudi patients reach its US campuses and London clinic, a move that should make UAE hospitals, insurers and patients reassess how complex cross-border referrals are managed.

The highest-stakes readers are COOs, CFOs and medical directors. For Dubai providers, the issue is referral control: a Saudi patient can now get local Arabic-language help on appointments, records, travel, billing and follow-up before leaving the Gulf. For insurers, it tightens the paperwork and authorisation burden. For clinical leaders, it raises the bar on second opinions, discharge summaries and continuity after a patient returns.

What Mayo has put in Riyadh

Gulf Business published the interview on 2 September 2026. Dr Omar Ghanem, Mayo Clinic's medical director for the Middle East, said the office is aimed at patients with complex, rare or undiagnosed conditions who may need highly specialised care abroad.

"This is not about replacing local care but complementing it." Dr Omar Ghanem, Mayo Clinic medical director for the Middle East

The office is not licensed as a treatment facility. Mayo's own Riyadh representative office listing names Mohammed Saeed Alrashidi as representative, gives Arabic and English as languages, and lists office hours as 9 a.m. to 5 p.m. AST, Sunday to Thursday. Mayo says patients can seek appointments in Rochester, Minnesota; Phoenix and Scottsdale, Arizona; Jacksonville, Florida; and Mayo Clinic Healthcare in London.

The UAE already has a Mayo representative office. Mayo's Dubai listing names Wesam Dawood, based at Office 401, Al Jalila Foundation, Dubai Healthcare City, with hours of 8 a.m. to 5 p.m. UAE time, Monday to Friday. It also says representatives are available to referring physicians and insurance brokers.

Why Dubai operators should care first

Dubai is the UAE market most exposed to regional medical travel. The Dubai Health Authority (DHA) regulates providers in the emirate, while Dubai Healthcare City has its own health regulation route. A Riyadh office gives Saudi patients another route to a US tertiary brand before they choose Dubai for oncology, transplant evaluation, neurology, complex orthopaedics or executive diagnostics.

For COOs, the immediate task is process discipline. Mayo says international medical records must be in English before review. Dubai providers handling second opinions should check whether radiology discs, pathology slides, operative notes and medication lists can be exported within 5 working days. That target is operational, not regulatory. It gives case managers a measurable service level when a patient is comparing Dubai with a US or London pathway.

For CFOs, the cost question is pre-authorisation, not headline treatment price. Mayo states costs are patient-specific and may involve deposits for international patients. UAE operators should avoid quoting Mayo procedure prices unless they have a written estimate from Mayo's International Finance team. In Dubai, commercial plans, including Sukoon global health products, can differ by annual limit and overseas coverage. Sukoon's public HealthPlus page states cover can range from AED 150,000 to AED 5,000,000, depending on plan selection.

• Ask whether the insurer covers elective treatment outside the UAE.
• Get written pre-authorisation before records leave the UAE provider.
• Separate the second-opinion fee, travel deposit and inpatient estimate.
• Assign one case manager for records, billing and discharge follow-up.

Abu Dhabi and the northern emirates

In Abu Dhabi and Al Ain, the Department of Health - Abu Dhabi (DOH) regulates licensed providers. Thiqa is managed by Daman and serves more than 1 million members, according to Thiqa's public site. Thiqa's FAQ says non-emergency, non-life-threatening treatment outside the UAE is not covered unless the member has purchased Musafer. That matters when a patient asks a DOH-regulated hospital to support a Mayo referral after a domestic specialist has already advised local treatment.

In Sharjah, Ajman, Umm Al Quwain, Ras Al Khaimah and Fujairah, the Ministry of Health and Prevention (MOHAP) is the relevant federal regulator for private healthcare licensing. MOHAP's treatment-abroad service is for UAE nationals requesting care outside the country. Providers in the northern emirates should check whether the patient is using MOHAP sponsorship, private insurance or self-pay before sending clinical documents.

Dubai's own overseas treatment bylaw gives a useful benchmark for documentation. The 2017 DHA bylaw requires a medical report from a government or accredited private hospital, dated no earlier than 30 days before application. In some cases, DHA may require a report dated within 2 weeks. It also states that a patient leaving the host country may receive up to 4 weeks of prescribed medication, based on the treating physician's report.

The practical implication is narrow. UAE clinics should treat Mayo's Riyadh move as a referral-service benchmark. Insurers should update call-centre scripts for international second opinions. Patients should verify the UAE licence status of local providers before starting a complex referral. For a licensed local option, start with the UAE Open Healthcare Directory for hospitals and providers.